APA način citiranja

Kucerova, L., Demkova, L., Skolekova, S., Bohovic, R., & Matuskova, M. (2016). Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation. BMC Cancer.

Čikaški stil citiranja

Kucerova, Lucia, Lucia Demkova, Svetlana Skolekova, Roman Bohovic, i Miroslava Matuskova. "Tyrosine Kinase Inhibitor SU11274 Increased Tumorigenicity and Enriched for Melanoma-initiating Cells By Bioenergetic Modulation." BMC Cancer 2016.

MLA način citiranja

Kucerova, Lucia, et al. "Tyrosine Kinase Inhibitor SU11274 Increased Tumorigenicity and Enriched for Melanoma-initiating Cells By Bioenergetic Modulation." BMC Cancer 2016.